Skip to content

Clinical trials

Phase 2 Communicable Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Communicable Diseases Phase: Phase 2 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20131
20152
20172
20202
20211
20221
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Terminated3
Active, not recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lisa Flowers2
National Institute of Allergy and Infectious Diseases (NIAID)2
Vanderbilt University Medical Center2
60 Degrees Pharmaceuticals LLC1
Astellas Pharma Inc1
AusperBio Therapeutics Inc.1
Charles Drew University of Medicine and Science1
Emory University1
Gilead Sciences1
Immorna Biotherapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Communicable Diseases21
Infections5
Influenza, Human4
Immune System Diseases3
Neoplasms3
Rare Diseases3
Liver Diseases2
Virus Diseases2
Acquired Immunodeficiency Syndrome1
Anemia1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.